Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.

Chapman MA, Sive J, Ambrose J, Roddie C, Counsell N, Lach A, Abbasian M, Popat R, Cavenagh JD, Oakervee H, Streetly MJ, Schey S, Koh M, Willis F, Virchis AE, Crowe J, Quinn MF, Cook G, Crawley CR, Pratt G, Cook M, Braganza N, Adedayo T, Smith P, Clifton-Hadley L, Owen RG, Sonneveld P, Keats JJ, Herrero J, Yong K.

Blood. 2018 Nov 15;132(20):2154-2165. doi: 10.1182/blood-2018-05-849893. Epub 2018 Sep 4.

2.

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors.

Sausville E, Lorusso P, Carducci M, Carter J, Quinn MF, Malburg L, Azad N, Cosgrove D, Knight R, Barker P, Zabludoff S, Agbo F, Oakes P, Senderowicz A.

Cancer Chemother Pharmacol. 2014 Mar;73(3):539-49. doi: 10.1007/s00280-014-2380-5. Epub 2014 Jan 22.

3.

Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumors.

Lorusso PM, Edelman MJ, Bever SL, Forman KM, Pilat M, Quinn MF, Li J, Heath EI, Malburg LM, Klein PJ, Leamon CP, Messmann RA, Sausville EA.

J Clin Oncol. 2012 Nov 10;30(32):4011-6. doi: 10.1200/JCO.2011.41.4946. Epub 2012 Oct 1.

4.

Long-term cost-effectiveness of weight management in primary care.

Trueman P, Haynes SM, Felicity Lyons G, Louise McCombie E, McQuigg MS, Mongia S, Noble PA, Quinn MF, Ross HM, Thompson F, Broom JI, Laws RA, Reckless JP, Kumar S, Lean ME, Frost GS, Finer N, Haslam DW, Morrison D, Sloan B; Counterweight Project Team.

Int J Clin Pract. 2010 May;64(6):775-83. doi: 10.1111/j.1742-1241.2010.02349.x. Epub 2010 Mar 29.

PMID:
20353431
5.

Engaging patients, clinicians and health funders in weight management: the Counterweight Programme.

Counterweight Project Team, McQuigg M, Brown JE, Broom JI, Laws RA, Reckless JP, Noble PA, Kumar S, McCombie EL, Lean ME, Lyons GF, Mongia S, Frost GS, Quinn MF, Barth JH, Haynes SM, Finer N, Haslam DW, Ross HM, Hole DJ, Radziwonik S.

Fam Pract. 2008 Dec;25 Suppl 1:i79-86. doi: 10.1093/fampra/cmn081. Epub 2008 Nov 27.

PMID:
19042914
6.

The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change.

McQuigg M, Brown JE, Broom J, Laws RA, Reckless JP, Noble PA, Kumar S, McCombie EL, Lean ME, Lyons FG, Frost GS, Quinn MF, Barth JH, Haynes SM, Finer N, Haslam DW, Ross HM, Hole DJ, Radziwonik S.

Obes Res Clin Pract. 2008 Mar;2(1):I-II. doi: 10.1016/j.orcp.2008.01.002.

PMID:
24351674
7.

Empowering primary care to tackle the obesity epidemic: the Counterweight Programme.

McQuigg M, Brown J, Broom J, Laws RA, Reckless JP, Noble PA, Kumar S, McCombie EL, Lean ME, Lyons GF, Frost GS, Quinn MF, Barth JH, Haynes SM, Finer N, Ross HM, Hole DJ; Counterweight Project Team.

Eur J Clin Nutr. 2005 Aug;59 Suppl 1:S93-100; discussion S101.

PMID:
16052202
8.

Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR.

Thompson A, Quinn MF, Grimwade D, O'Neill CM, Ahmed MR, Grimes S, McMullin MF, Cotter F, Lappin TR.

Blood. 2003 Feb 15;101(4):1558-65.

PMID:
12560242
9.

Cyclic adenosine 3',5'-monophosphate increases the open probability of potassium channels in activated human T cells.

Oleson DR, DeFelice LJ, Quinn MF, Donahoe RM.

J Immunol. 1996 Aug 1;157(3):1080-6.

PMID:
8757612
10.

Spontaneous hepatic hemorrhage in preeclampsia: treatment with hepatic arterial embolization.

Terasaki KK, Quinn MF, Lundell CJ, Finck EJ, Pentecost MJ.

Radiology. 1990 Mar;174(3 Pt 2):1039-41.

PMID:
2305086
11.
12.

Transpancreatic catheterization of the right hepatic artery for chemoembolization using a new infusion system.

Quinn MF, Lundell CJ, Daniels JR, Vegh GB, Engelson ET.

Cathet Cardiovasc Diagn. 1988;14(2):115-7.

PMID:
3365761
13.

Stab wounds to the extremities: indications for angiography.

Quinn MF, Lundell CJ.

Radiology. 1987 Oct;165(1):291-2. No abstract available.

PMID:
3628789
14.

Reliability of selective pulmonary arteriography in the diagnosis of pulmonary embolism.

Quinn MF, Lundell CJ, Klotz TA, Finck EJ, Pentecost M, McGehee WG, Garnic JD.

AJR Am J Roentgenol. 1987 Sep;149(3):469-71.

PMID:
3497530
15.

Traumatic laceration of the ascending aorta: angiographic assessment.

Lundell CJ, Quinn MF, Finck EJ.

AJR Am J Roentgenol. 1985 Oct;145(4):715-9.

PMID:
3875987
16.

Spectral shifting by dyes to enhance algae growth.

Prokop A, Quinn MF, Fekri M, Murad M, Ahmed SA.

Biotechnol Bioeng. 1984 Nov;26(11):1313-22.

PMID:
18551655
17.

Experimental measurements of the downward infrared sky radiation to Kuwait.

Quinn MF, Alameddine O, Al-Jamal K.

Appl Opt. 1984 Feb 1;23(3):419. No abstract available.

PMID:
18204577
18.

Patterns of resolution in successfully treated hepatic amebic abscess: sonographic evaluation.

Ralls PW, Quinn MF, Boswell WD Jr, Colletti PM, Radin DR, Halls J.

Radiology. 1983 Nov;149(2):541-3.

PMID:
6622702
19.

Sonographic findings in hepatic amebic abscess.

Ralls PW, Colletti PM, Quinn MF, Halls J.

Radiology. 1982 Oct;145(1):123-6.

PMID:
7122867
20.

Predicting the cause of common bile duct obstruction with sonographic data: analysis of binary variables.

Quinn MF, Ralls PW, Boswell WD, Lapin SA, Morris UL, Halls JM.

Invest Radiol. 1982 May-Jun;17(3):316-23.

PMID:
6749755
21.

Sonography of pyogenic splenic abscess.

Ralls PW, Quinn MF, Colletti P, Lapin SA, Halls J.

AJR Am J Roentgenol. 1982 Mar;138(3):523-5.

PMID:
7039270
22.

Prospective evaluation of the sonographic Murphy sign in suspected acute cholecystitis.

Ralls PW, Halls J, Lapin SA, Quinn MF, Morris UL, Boswell W.

J Clin Ultrasound. 1982 Mar;10(3):113-5.

PMID:
6804512
23.

Thickening of the gallbladder wall in acute hepatitis: ultrasound demonstration.

J├╝ttner HU, Ralls PW, Quinn MF, Jenney JM.

Radiology. 1982 Feb;142(2):465-6.

PMID:
7054838
24.

Sonography in the diagnosis and management of hepatic amebic abscess in children.

Ralls PW, Mikity VG, Colletti P, Boger D, Halls J, Quinn MF.

Pediatr Radiol. 1982;12(5):239-43.

PMID:
7177733
25.

Biliary sonography: ventral bowing of the dilated common duct.

Ralls PW, Quinn MF, Halls J.

AJR Am J Roentgenol. 1981 Dec;137(6):1127-9. No abstract available.

PMID:
6976079
26.

Gallbladder wall thickening: patients without intrinsic gallbladder disease.

Ralls PW, Quinn MF, Juttner HU, Halls JM, Boswell WD.

AJR Am J Roentgenol. 1981 Jul;137(1):65-8.

PMID:
6787892
27.

Sonographic anatomy of the hepatic artery.

Ralls PW, Quinn MF, Rogers W, Halls J.

AJR Am J Roentgenol. 1981 Jun;136(6):1059-63.

PMID:
6786013
28.

Sonography in recurrent oriental pyogenic cholangitis.

Ralls PW, Colletti PM, Quinn MF, Lapin SA, Morris UL, Halls J.

AJR Am J Roentgenol. 1981 May;136(5):1010-2. No abstract available.

PMID:
6784500
29.

CT of brainstem injury.

Tsai FY, Teal JS, Quinn MF, Itabashi HH, Huprich JE, Ahmadi J, Segall HD.

AJR Am J Roentgenol. 1980 Apr;134(4):717-23.

PMID:
6767357
30.

Ultrasonographic diagnosis of post-percutaneous renal biopsy hematoma.

Ralls PW, Colletti P, Boger DC, Quinn MF, Halls J.

Urol Radiol. 1980;2(1):23-4.

PMID:
7233638
31.

Projection equipment: some criteria for selection.

Quinn MF.

Scott Med J. 1971 Jan;16(1):92-7. No abstract available.

PMID:
4105157
32.

DRUG COMBINATIONS IN THE TREATMENT OF NEWLY ADMITTED, ACUTELY ILL PSYCHIATRIC PATIENTS; PRELIMINARY REPORT.

AGALLIANOS DD, OTA KY, QUINN MF, TEPPER SR, KURLAND AA.

Curr Ther Res Clin Exp. 1964 Oct;6:626-37. No abstract available.

PMID:
14219592

Supplemental Content

Loading ...
Support Center